Evidence review

VIP for Muscle Loss: Preclinical Signals on Vasoactive Intestinal Peptide

#peptide#matrix
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects (paste without context)

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `vip-muscle-loss`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/vip-muscle-loss

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/vip-muscle-loss/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Paste-ready package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/vip-muscle-loss/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/vip-muscle-loss/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/vip-muscle-loss/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why VIP might help you

  1. Therefore for you: If that layer is part of your problem, VIP is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • VIP → immune / autonomic

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 4
  • Claims tagged human evidence: 1
  • Claims tagged preclinical (animal/lab): 3
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 5

Quantified confidence (this ledger): 0.36 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Activation of the vasoactive intestinal peptide 2 receptor modulates skeletal muscle mass and force (source s1)

2005 rodent study on VPAC2 activation and muscle preservation.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Ischemic-reperfused rat skeletal muscle: the effect of vasoactive intestinal peptide (source s2)

1997 rat ischemia-reperfusion study with VIP.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Vasoactive intestinal peptide-deficient mice show altered body composition (source s3)

Mouse knockout study on VIP and lean mass.

Evidence type: Animal or lab work — shows mechanism or early signal, not proof in people.

Recent advances in vasoactive intestinal peptide physiology (source s4)

2019 review confirming lack of muscle-specific human trials.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

The peptide nobody talks about but everyone should: VIP — Reddit, r/Biohack_Blueprint (source s5)

Anecdotal Reddit discussion on VIP uses.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Muscle loss / sarcopenia · condition map

Evidence map

Hover a node — its path lights up. Click to open the article.

Full map →
JumpVIP for Statin-Associated Cognitive Effects: Evidence Review · 2 humanVIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomi… · 2 humanVIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Review · 2 humanVIP for Diabetic Neuropathy: Evidence-Graded Overview · 2 human
Evidence · 5 sources · swipe →chain 53091e66d70c · verify chain · provenance
1 / 5
Evidence ledger 5 · tier-ranked · API
preclinical
VIP administration at reperfusion onset increased contractile force and tissue oxygenation in ischemic-reperfused rat skeletal muscle.
sources: s2
humanlow confidence
No human clinical trials test VIP for muscle loss or sarcopenia.
sources: s4
preclinicallow confidence
Activation of VPAC2 receptors with VIP agonists reduced loss of skeletal muscle mass and force in rodent disuse models.
sources: s1
preclinicallow confidence
VIP knockout mice had lower body weight, lower fat mass, and increased lean mass percentage.
sources: s3
anecdotallow confidence
Reddit users discuss VIP anecdotally for inflammation recovery or training pumps but not direct muscle gain.
sources: s5
Model swipes · 1 from 1 model · swipe →verify
1 / 1
grok/grok-4.3writer
redraft2026-06-29 22:28
VIP for Muscle Loss: Preclinical Signals on Vasoactive Intestinal Peptide · 5 claims · 5 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: Vip for Muscle Loss
Slug: vip-muscle-loss
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"vip","name":"VIP"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_layers":[
it output
{
  "slug": "vip-muscle-loss",
  "title": "VIP for Muscle Loss: Preclinical Signals on Vasoactive Intestinal Peptide",
  "body": "## What's breaking down\nMuscle loss, or atrophy, occurs when breakdown outruns repair in skeletal muscle tissue. Layers include disuse from reduced activity, age-related sarcopenia with declining anabolic signals, inflammation that promotes protein breakdown via pathways like MuRF1, and impaired blood flow or oxygenation that limits nutrient delivery and waste removal. In disuse or ischemia models, contractile force drops as muscle fibers shrink. VIP sits in the immune and autonomic layer because it modulates inflammation and smooth muscle tone in vessels, potentially supporting repair signals rather than suppressing symptoms directly.\n\n## Why VIP might help you\nIf your muscle loss involves an immune or autonomic component, such as chronic low-grade inflammation accelerating protein breakdown or autonomic imbalance affecting blood flow, VIP is discussed for its studied effects on tissue repair pathways. Step one: VIP activates VPAC2 receptors, which in lab models reduced skeletal muscle mass loss during disuse. Step two: This receptor activation preserved force generation, pointing to a direct influence on muscle maintenance rather than masking fatigue. Step three: In reperfusion settings after ischemia, VIP raised contractile force and tissue ox
ab3c7fcfa3c02e16

Related research

Muscle loss / sarcopenia · condition map

Open evidence map →
VipvipVIP for Benzodiazepine Withdrawal: Evidence Reviewvip-benzo-withdrawalVIP and Benzodiazepines: Immune and Autonomic Pathways in a Suppressio…vip-benzodiazepinesVIP for Statin-Associated Cognitive Effects: Evidence Reviewvip-brain-fogVIP for Carpal Tunnel Syndrome: A Data-First Evidence Reviewvip-carpal-tunnelVIP Peptide for Chemotherapy Contexts: Evidence on Immune and Autonomi…vip-chemoVIP for Chemotherapy-Induced Neuropathy: A Data-First Evidence Reviewvip-chemo-neuropathyVIP for Cognition: Evidence on Vasoactive Intestinal Peptidevip-cognitionVIP and Corticosteroid Injections: Evidence Layers on Immune Modulatio…vip-corticosteroidsVIP for Diabetic Neuropathy: Evidence-Graded Overviewvip-diabetic-neuropathy
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (preclinical tier): "VIP administration at reperfusion onset increased contractile force and tissue oxygenation in ischemic-reperfused rat skeletal muscle."?
ask vip-muscle-loss claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "No human clinical trials test VIP for muscle loss or sarcopenia."?
ask vip-muscle-loss claim c4 · paste includes §SELF
What does the ledger say about this (preclinical tier): "Activation of VPAC2 receptors with VIP agonists reduced loss of skeletal muscle mass and force in rodent disuse models."?
ask vip-muscle-loss claim c1 · paste includes §SELF
What does the ledger say about this (preclinical tier): "VIP knockout mice had lower body weight, lower fat mass, and increased lean mass percentage."?
ask vip-muscle-loss claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users discuss VIP anecdotally for inflammation recovery or training pumps but not direct muscle gain."?
ask vip-muscle-loss claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "Anecdotal Reddit discussion on VIP uses."
ask vip-muscle-loss source s5 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about VIP for Muscle Loss: Preclinical Signals on Vasoactive Intestinal Peptide — and what would you need me to tell you first?
ask vip-muscle-loss condition gaps · paste includes §SELF
What good and bad outcomes are documented for VIP for Muscle Loss: Preclinical Signals on Vasoactive Intestinal Peptide (studies vs anecdotes)?
ask vip-muscle-loss good bad experiences · paste includes §SELF
vip-muscle-loss · posted 2026-06-29 · updated 2026-06-29 · 1 prior revision · grok/grok-4.3
Ledger API & provenance
Provenance · 1 model pass · 17557 tokens · $0 · 1 model
chain head 51f30a41dda599e0
write grok/grok-4.3 · 2026-06-29 22:28 · 17557 tok · 51f30a41dda5
verify chain →
Live ledger · 6 payloads · 1 turn
recent activity · inspect
webhook_in blooio · 2026-06-29 22:28
webhook_in blooio · 2026-06-29 22:28
PROTOCOL_RUN dispatch · 2026-06-29 22:28 · t_n9aciz7k
PROTOCOL_RUN dispatch · 2026-06-29 22:28 · t_n9aciz7k
webhook_in blooio · 2026-06-29 22:28
webhook_in blooio · 2026-06-29 22:28
view full ledger & cards →
REST + ledger
read GET /api/articles/vip-muscle-loss · GET /api/articles/vip-muscle-loss?format=post (the editable body)
create/replace POST /api/articles/vip-muscle-loss · PUT /api/articles/vip-muscle-loss (replace, keeps revision) · PATCH /api/articles/vip-muscle-loss (merge)
delete DELETE /api/articles/vip-muscle-loss
writes need header x-terminal-key
ledger provenance · sources · contributions · revisions · live ledger & cards
LLM bundle GET /api/articles/vip-muscle-loss/bundle?format=markdown — body + claims + sources + provenance + manifest
voxel graph GET /api/articles/vip-muscle-loss/voxels · constitution · ontology
post claim POST /api/protocol/claim · iMessage claim vip-muscle-loss|tier|assertion
system map GET /api/articles/system-map?format=markdown — root index; every widget self-explains via §SELF / _self
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →